In an effort to stop the mosquito-borne Zika virus, scientists are using genetically modified mosquitos. The illness, which does not have a vaccine and cannot be prevented by drugs, is currently the cause of a travel advisory issued by the Center for Disease Control (CDC). The outbreak has reached pandemic proportions in South America.
Biotechnical insect control company Oxitech developed a strain of genetically engineered mosquitos that mimic the ones that carry Zika virus and the similar Dengue Fever. Through their tests they have been able to significantly reduce (by 90%) the mosquito population in Brazil. This could have a huge impact on the spread of the Zika virus and holds much potential for other diseases like Malaria.
Disease-Fighting Insects
Oxitech's Genetically Modified Mosquitos are Fighting the Zika Virus
Trend Themes
-
Genetic Modification of Insects — The use of genetically modified insects, like Oxitech's mosquitos, to combat disease outbreaks such as the Zika virus.
-
Biotechnical Insect Control — The development and implementation of innovative techniques to control insect populations and reduce the spread of diseases.
-
Innovative Disease Prevention Methods — Exploring new and unconventional methods, such as genetic modification, to prevent and control diseases transmitted by insects.
Industry Implications
-
Biotechnology — The biotechnology industry can leverage genetic modification techniques to develop innovative strategies for disease control.
-
Public Health — The public health sector can benefit from the use of genetically modified insects in controlling disease outbreaks and preventing their spread.
-
Agriculture — The agricultural industry can explore biotechnical insect control methods to protect crops from insect-related diseases and minimize the use of pesticides.